Saltar al contenido
Merck
Todas las fotos(1)

Key Documents

View All Documentation

S5814

Sigma-Aldrich

Stop Reagent for TMB Substrate

chromogenic, powder

Sinónimos:

TMB liquid substrate system stop reagent

Iniciar sesiónpara Ver la Fijación de precios por contrato y de la organización
Todas las fotos(1)

About This Item

UNSPSC Code:
12352204
NACRES:
NA.83

product name

Stop Reagent for TMB Substrate, powder, ELISA, 450 nm

form

powder

storage temp.

room temp

General description

Stop Reagent for TMB Substrate is used to stop TMB substrate reaction for ELISA and change the absorbance from blue (620 nm) to yellow (450 nm).

Application

Stop Reagent for TMB Substrate has been used:
  • for in vitro preparation and analysis of neutrophil extracellular traps (NETs)
  • for direct binding enzyme linked immune sorbent assay (ELISA)
  • for interference assay

pictograms

CorrosionExclamation mark
GHS05,GHS07

signalword

Danger

Hazard Classifications

Acute Tox. 4 Dermal - Acute Tox. 4 Oral - Eye Dam. 1 - Skin Corr. 1 - Skin Sens. 1 - STOT SE 3

target_organs

Respiratory system

Storage Class

8A - Combustible corrosive hazardous materials

wgk_germany

WGK 3

flash_point_f

260.6 °F - closed cup

flash_point_c

127 °C - closed cup

Certificados de análisis (COA)

Busque Certificados de análisis (COA) introduciendo el número de lote del producto. Los números de lote se encuentran en la etiqueta del producto después de las palabras «Lot» o «Batch»

¿Ya tiene este producto?

Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.

Visite la Librería de documentos

Romesh R Subramanian et al.
Nucleic acids research, 43(19), 9123-9132 (2015-10-09)
The in vivo potency of antisense oligonucleotides (ASO) has been significantly increased by reducing their length to 8-15 nucleotides and by the incorporation of high affinity RNA binders such as 2', 4'-bridged nucleic acids (also known as locked nucleic acid
Myeloid-specific deletion of peptidylarginine deiminase 4 (PAD4) mitigates atherosclerosis.
Liu Y, et al.
Frontiers in Immunology, 9, 1680-1680 (2018)
Prevalence of interfering antibodies in dogs and cats evaluated using a species-independent assay
Bergman D, et al.
Veterinary Clinical Pathology / American Society For Veterinary Clinical Pathology, 47(2), 205-212 (2018)
Marília Santini-Oliveira et al.
Vaccines, 10(10) (2022-10-28)
We report the successful closure of Phase I clinical trials, comprising Phases Ia and Ib, of the vaccine candidate against human schistosomiasis: the Schistosoma mansoni 14 kDa fatty acid-binding protein (Sm14) + glucopyranosyl lipid A in squalene emulsion (GLA-SE). Shown
Fresthel Monica M Climacosa et al.
Protein and peptide letters, 27(10), 962-970 (2020-04-29)
Microbe-Binding Peptides (MBPs) are currently being investigated to address the problem of antimicrobial resistance. Strategies enhancing their antimicrobial activity have been developed, including peptide dimerization. Here, we present an alternative approach based on peptide polymerization, yielding hapten-labelled polymeric MBPs that
Ver todos los artículos relacionados

Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.

Póngase en contacto con el Servicio técnico